Skip to content

Prospective observational study of the natural history of patients with retinitis pigmentosa: the KEYS study

Prospective observational study of the natural history of patients with retinitis pigmentosa: the KEYS study - Prospective observational study of the natural history of patients with retinitis pigmentosa: the KEYS study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000057025
Enrollment
50
Registered
2025-02-28
Start date
2021-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinitis pigmentosa

Interventions

None listed

Sponsors

Santen Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who have been diagnosed with retinitis pigmentosa in both eyes

Exclusion criteria

Exclusion criteria: Any decision by the Investigator to terminate a subject in screening

Design outcomes

Primary

MeasureTime frame
Visual function (Corrected visual acuity, Visual field, etc.)

Countries

Japan

Contacts

Public ContactYuki Togashi

Santen Pharmaceutical Co., Ltd. Ophthalmology Innovation Center

translational.research@santen.com06-4802-9339

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026